Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Drug Metabolism Reviews|August 30, 2023
Drug transporters in drug disposition - the year 2022 in reviewParesh P Chothe, Pallabi Mitra, Masanori Nakakariya, et al.Drug Metabolism Reviews|June 28, 2022
Novel insights in drug transporter sciences: the year 2021 in reviewParesh P Chothe, Pallabi Mitra, Masanori Nakakariya, et al.Drug Metabolism Reviews|June 23, 2026
Drug Transporters in Drug Disposition - Highlights from the Year 2025Philip Sandoval, Pallabi Mitra, Masanori Nakakariya, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 25, 2017
Quantitative Prediction of CYP3A4 Induction: Impact of Measured, Free, and Intracellular Perpetrator Concentrations from Human Hepatocyte Induction Studies on Drug-Drug Interaction PredictionsYongkai Sun, Paresh P Chothe, Jennifer E Sager, et al.Drug Metabolism Reviews|July 25, 2025
Drug transporters in drug disposition - highlights from the year 2024Philip Sandoval, Pallabi Mitra, Upendra A Argikar, et al.Drug Metabolism Reviews|September 2, 2024
Drug transporters in drug disposition - highlights from the year 2023Paresh P Chothe, Upendra A Argikar, Pallabi Mitra, et al.Journal of Pharmaceutical Sciences|October 19, 2024
Evaluation of the impact of the polymer end groups and molecular weight on in vitro and in vivo performances of PLGA based in situ forming implants for ketoprofenSanjib Saha, Xinhao Lin, Liping Zhou, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 11, 2022
Sinusoidal Uptake Determines the Hepatic Clearance of Pevonedistat (TAK-924) as Explained by Extended Clearance ModelPhilip Sandoval, Bei-Ching Chuang, Lawrence Cohen, et al.CPT: Pharmacometrics & Systems Pharmacology|December 21, 2022
Predicting changes in the pharmacokinetics of CYP3A-metabolized drugs in hepatic impairment and insights into factors driving these changesMayur K Ladumor, Flavia Storelli, Xiaomin Liang, et al.CPT: Pharmacometrics & Systems Pharmacology|October 14, 2023
Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance modelFlavia Storelli, Mayur K Ladumor, Xiaomin Liang, et al.Pageof 4